论文部分内容阅读
用比索洛尔治疗 70例肺心病伴不同类型的室上性心动过速 ,与同期住院肺心病患者治疗前后血气结果相对照。结果表明用比索洛尔 2 5mg ,每日 2次口服 ,对室上性心动过速总有效率达 77 1%,其中对阵发性室上性心动过速和反复短阵发作性房速的疗效优于多源性房速。临床上无应用比索洛尔后气道阻力增加的表现 ,证明比索洛尔对肺心病伴室上速疗效肯定 ;肺心病患者即使在急性加重期亦能很好耐受治疗剂量的比索洛尔
Treatment of 70 cases of pulmonary heart disease with bisoprolol with different types of supraventricular tachycardia, and hospitalized patients with pulmonary heart disease over the same period before and after treatment of blood gas results. The results showed that with bisoprolol 25mg, 2 times a day orally, the total effective rate of supraventricular tachycardia reached 77 1%, of which paroxysmal supraventricular tachycardia and repeated short-term episodes of the effect of atrial tachycardia Superior to multi-source atrial tachycardia. The clinical application of bisoprolol without airway resistance increased performance, confirmed that bisoprolol on pulmonary heart disease with supraventricular tachycardia positive; pulmonary heart disease patients in the acute exacerbation of the well tolerated dose of bisoprolol